Compare CORT & VOYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CORT | VOYA |
|---|---|---|
| Founded | 1998 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 8.8B |
| IPO Year | 2001 | 2012 |
| Metric | CORT | VOYA |
|---|---|---|
| Price | $63.63 | $95.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 12 |
| Target Price | ★ $142.60 | $109.75 |
| AVG Volume (30 Days) | ★ 1.2M | 942.4K |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.36% |
| EPS Growth | N/A | ★ 1.94 |
| EPS | 1.13 | ★ 4.82 |
| Revenue | $761,407,000.00 | ★ $8,189,000,000.00 |
| Revenue This Year | $52.09 | N/A |
| Revenue Next Year | $44.73 | $4.53 |
| P/E Ratio | $57.37 | ★ $20.08 |
| Revenue Growth | ★ 12.79 | 1.73 |
| 52 Week Low | $28.66 | $64.50 |
| 52 Week High | $126.38 | $106.79 |
| Indicator | CORT | VOYA |
|---|---|---|
| Relative Strength Index (RSI) | 20.65 | 39.75 |
| Support Level | $30.24 | $91.03 |
| Resistance Level | $122.93 | $103.02 |
| Average True Range (ATR) | 4.77 | 3.56 |
| MACD | -0.14 | -0.73 |
| Stochastic Oscillator | 1.89 | 3.85 |
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
Voya Financial Inc is a financial services company, which, through its subsidiaries, provides various investment, insurance, and retirement solutions to individual and institutional clients in the United States. Its products and services include tax savings plans, individual retirement accounts, group life insurance plans, and employee benefits products, among others. The company tailors each of its products to the needs of its customer base. It operates its business through three principal lines: Retirement, Investment Management and Employee Benefits.The majority revenue is from Retirement segment.